Novel inhibitors of beta-lactamase

Details for Australian Patent Application No. 2007300531 (hide)

Owner Merck & Co., Inc.

Inventors Mortko, Christopher J.; Blizzard, Timothy A.; Kim, Seongkon; Ha, Sookhee; Chiu, Anna; Variankaval, Narayan; Chen, Helen Y.; Wu, Jane Yang

Agent Spruson & Ferguson

Pub. Number AU-A-2007300531

PCT Pub. Number WO2008/039420

Priority 60/847,453 27.09.06 US

Filing date 24 September 2007

Wipo publication date 3 April 2008

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/039420 Priority application(s): WO2008/039420

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300532-Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitor chelate complexes

2007300529-Acylated piperidine derivatives as melanocortin-4 receptor modulators